Status:
UNKNOWN
Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward
Lead Sponsor:
Taipei Medical University
Collaborating Sponsors:
Ministry of Science and Technology, Taiwan
Taipei Medical University Hospital
Conditions:
End Stage Cancer
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.
Detailed Description
This study aims to develop a deep-learning-based survival prediction model that utilizes patient movement data upon admission to predict their clinical outcomes: either death or discharge with stable ...
Eligibility Criteria
Inclusion
- Participants aged 20 years or older admitted to the hospice care unit at Taipei Medical University Hospital
- Participants diagnosed with at least one end-stage solid tumor diseases
- Participants consented to receive hospice care
Exclusion
- Participants aged below 20 years of age
- Participants diagnosed with leukemia or carcinoma of unknown primary
- Participants with evident signs of approaching death upon admission
- Participants with no vital signs upon admission
- Participants who continued to receive aggressive treatment despite admission to the hospice care unit
Key Trial Info
Start Date :
December 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04883879
Start Date
December 11 2019
End Date
December 31 2021
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University
Taipei, TW - Taiwan, Taiwan, 110